Because a normal-looking hormone level in perimenopause tells you very little.

In this transition, FSH and estrogen can swing between premenopausal and postmenopausal ranges within the same month, sometimes within weeks, in the same woman. Early research that tracked women's hormones weekly over months found patterns that varied widely both between individual women and from week to week in the same woman, including postmenopausal-range readings that resolved and ovulatory cycles that continued right up until close to the final period. Even within a single cycle in women aged 45-55, researchers found normal FSH could coexist with clear signs of the transition elsewhere in the hormone profile. A normal single test is fully compatible with being in perimenopause - it does not rule it out.

What to know about this answer

There isn't real scientific disagreement that a single normal FSH doesn't rule perimenopause out - the evidence on hormone variability is decades old, consistent, and confirmed at population scale. The practical tension is that some clinicians still use a normal result to dismiss the possibility, which the source material flags repeatedly as a specific, avoidable error.

What the research shows, and which source each finding rests on

Weekly hormone sampling of 31 perimenopausal women over a median of 43 weeks found hormone patterns 'varied widely, both between individuals and from time to time in the same individual'; postmenopausal-range FSH elevations lasting 1-2 weeks occurred and then resolved, and ovulatory cycles were observed at all stages, including within 16 weeks of the final period in 7 of 13 women who became postmenopausal during the study. The authors concluded: 'Postmenopausal biochemical parameters are no guarantee of the postmenopausal state.'

A companion longitudinal study (8 women, weekly sampling before to 22-30 weeks after the final menstrual period) found 'no clear hormonal change occurred at the time of the menopause'; postmenopausal-range FSH/LH levels were common even before the final menstruation.

In the SWAN cohort (1,215 women), FSH begins rising about 6.1 years before the final period, accelerates about 2 years before, and does not stabilize until about 2 years after - a years-long moving target, not a threshold.

SWAN trajectory clustering identified four distinct estradiol trajectories and three distinct FSH trajectories across the transition - hormone trajectories are 'not uniform across the population of women,' so a single measurement cannot show which trajectory a woman is on.

Even within a single ovulatory cycle in women aged 45-55, endocrine profiles fell into at least three distinct types, from fully normal (except low AMH) to elevated FSH with normal estradiol - a normal FSH result is fully compatible with being in the transition.

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

A single normal test cannot rule perimenopause out

the decades of hormone-variability research, and clinicians such as Dr. Corinne Menn

The foundational weekly-sampling studies and the modern SWAN cohort agree: FSH and estradiol move too much, too fast, for one measurement to mean anything definitive, and clinicians who treat a normal result as disqualifying are making a documented, avoidable error.

What would settle it: Nothing further scientifically - this is settled. What would help is more consistent clinical training on the variability data itself, so a normal test result stops being used as a reason to dismiss symptoms.

What is really going on here

  1. Is my clinician using my bleeding pattern and symptoms as the primary evidence, or leaning mainly on a single lab result?
  2. If a test comes back normal, does that rule out perimenopause, or is that expected given how much hormones fluctuate?

Questions for your doctor

  1. Given how much FSH and estrogen fluctuate in perimenopause, are you ruling this out based on one test, or on my symptom and cycle history?
  2. Would repeating the test on a different day likely show a different result?
  3. What would change your assessment if the lab result and my symptoms disagree?
  4. Are there other conditions, like thyroid disease or iron deficiency, worth ruling out alongside this?

Questions with no answer yet

If a woman is tested on multiple different days across several weeks rather than once, would a clearer diagnostic pattern emerge than any single result can show?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The foundational research tracked hormones weekly over many months and found wide variability, which is exactly why a single test is unreliable, but no study has tested whether a defined multi-sample protocol, repeated over a shorter, practical timeframe, could offer better diagnostic information than one test while still being clinically feasible.

What would test it: A study testing a defined multi-sample protocol, for example three or four measurements over several weeks, against clinical diagnosis, to see whether the pattern of change adds useful information beyond symptoms and cycle history alone.

How often does a normal-looking hormone result actually change a clinician's mind about a woman's symptoms, compared with how often the symptoms and cycle history alone would have been enough?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The variability data explains why a normal result should not rule out perimenopause, but no study has directly measured how often, in real practice, a normal test result changes a clinical decision that the symptom and cycle history alone would not have already supported.

What would test it: A chart-review or prospective study tracking clinical decisions made with and without hormone testing in women with a clear symptom and cycle-change picture.

Sources

  1. 1.Pituitary-ovarian function in normal women during the menopausal transition.Metcalf MG, Donald RA, Livesey JH. Pituitary-ovarian function in normal women during the menopausal transition. Clin Endocrinol (Oxf) 1981;14(3):245-55. · Comparative or small study
  2. 2.Pituitary-ovarian function before, during and after the menopause: a longitudinal study.Metcalf MG, Donald RA, Livesey JH. Pituitary-ovarian function before, during and after the menopause: a longitudinal study. Clin Endocrinol (Oxf) 1982;17(5):489-94. · Observational study
  3. 3.Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period.Randolph JF Jr, Zheng H, Sowers MR, et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab 2011;96(3):746-54. · Observational study
  4. 4.Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN).Tepper PG, Randolph JF Jr, McConnell DS, et al. Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in SWAN. J Clin Endocrinol Metab 2012;97(8):2872-80. · Observational study
  5. 5.A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles.Robertson DM, Hale GE, Fraser IS, Hughes CL, Burger HG. A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles. Menopause 2008;15(6):1139-44. · Comparative or small study

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides